Lifesciences Archives

Pharma Procurement in 2025 and 2026: Key Challenges and How to Get Ahead

Pharma procurement teams are entering 2025 and 2026 with greater complexity, higher expectations, and tighter budgets. From managing supplier risk to adapting to cost volatility and rising compliance requirements, traditional approaches are no longer enough. Leading pharma companies are moving toward faster, AI-enabled models backed by industry expertise. This article outlines five key challenges procurement …

Pharma Procurement in 2025 and 2026: Key Challenges and How to Get Ahead Read More »

Beyond Cost: How to Evaluate CPL Vendors in Pharma and Biotech

When evaluating a Cost-Per-Lead (CPL) vendor in the pharma and biotech space, it’s critical to go beyond basic lead volume and assess their ability to deliver qualified, compliant, and strategically aligned leads that support your commercial and scientific goals. Here’s a breakdown of what to look for in a pharma/biotech CPL vendor: 🔬 1. Industry …

Beyond Cost: How to Evaluate CPL Vendors in Pharma and Biotech Read More »

ESG in Healthcare Procurement: What It Means for Medical Device and MedTech Companies

📉 The $3.8 Billion Wake-Up Call: A Shift in Hospital Procurement In 2023, a major U.S. hospital network canceled over $3.8 billion in long-term supply contracts with medical device manufacturers—not due to cost, but ESG misalignment. The suppliers, while clinically competitive, failed to meet new environmental and labor transparency criteria that the health system had …

ESG in Healthcare Procurement: What It Means for Medical Device and MedTech Companies Read More »

Beyond Drug Discovery: Predictive Analytics for Biotech B2B Lead Generation

Revolutionizing Biotech B2B Sales: The Power of Predictive Analytics In a boardroom filled with biotech executives, the conversation is no longer just about groundbreaking therapies—it’s about precision-targeted B2B lead generation. Imagine a world where contract research organizations (CROs), contract manufacturing organizations (CMOs), and biotech investors don’t just stumble upon opportunities but predict and capture them …

Beyond Drug Discovery: Predictive Analytics for Biotech B2B Lead Generation Read More »

Regulatory Compliance in Pharma: Proactive Risk Mitigation Through Media Monitoring

The Hidden Cost of Non-Compliance: A Lesson from the Headlines In 2019, a leading pharmaceutical company found itself in regulatory crosshairs after an investigative journalist exposed potential data discrepancies in its clinical trial reporting. The story spread like wildfire across media outlets, catching the attention of regulators worldwide. The company faced an immediate stock price …

Regulatory Compliance in Pharma: Proactive Risk Mitigation Through Media Monitoring Read More »

B2C Secret Weapons for B2B Medical Device Key Account Intelligence

The medical device industry is at a critical inflection point. As healthcare systems consolidate, purchasing decisions are becoming increasingly centralized within Integrated Delivery Networks (IDNs), Group Purchasing Organizations (GPOs), and large hospital networks. Traditional sales and marketing approaches that rely on relationship-based selling are no longer sufficient. To thrive, medical device manufacturers need data-driven Key …

B2C Secret Weapons for B2B Medical Device Key Account Intelligence Read More »

Pharma Conference Trends 2025: The Future of Pharma Events

The pharmaceutical industry is at the forefront of innovation, and its conferences must keep pace. As we approach 2025, Pharma Conference Trends are evolving rapidly, driven by AI-powered personalization, immersive technologies, and data-driven engagement strategies. No longer just large-scale gatherings, pharma events are becoming dynamic ecosystems that foster year-round knowledge exchange, strategic networking, and measurable …

Pharma Conference Trends 2025: The Future of Pharma Events Read More »

FAQs: KAI & ABM in Medical Devices: Answers to Your Top Questions

In the highly specialized medical device industry, success hinges on understanding your key accounts at a granular level. With purchasing decisions often involving multiple stakeholders—surgeons, administrators, and procurement teams—standardized approaches simply won’t cut it. This is where Key Account Intelligence and Account-Based Marketing (ABM) join forces to create highly personalized, results-driven strategies. From navigating the …

FAQs: KAI & ABM in Medical Devices: Answers to Your Top Questions Read More »

Reverse Engineering Competitors R&D Pipelines Biotech

Reverse Engineering Competitors’ R&D Pipelines: Ethical Insights for Biotech Firms

The boardroom was tense. The head of a biotech startup sat surrounded by her team, scrutinizing a recent patent application from a competitor. “They’re working on something big,” she said, her voice steady but urgent. “If we don’t figure out where they’re heading, we’ll be left behind.” In the fast-paced world of biotechnology, where innovation …

Reverse Engineering Competitors’ R&D Pipelines: Ethical Insights for Biotech Firms Read More »

perspective

Pharma Procurement in 2025 and 2026: Key Challenges and How to Get Ahead

Beyond Cost: How to Evaluate CPL Vendors in Pharma and Biotech

ESG in Healthcare Procurement: What It Means for Medical Device and MedTech Companies

Beyond Drug Discovery: Predictive Analytics for Biotech B2B Lead Generation

Regulatory Compliance in Pharma: Proactive Risk Mitigation Through Media Monitoring

B2C Secret Weapons for B2B Medical Device Key Account Intelligence

Pharma Conference Trends 2025: The Future of Pharma Events

FAQs: KAI & ABM in Medical Devices: Answers to Your Top Questions

Reverse Engineering Competitors’ R&D Pipelines: Ethical Insights for Biotech Firms

Marketing & Sales Solutions

Industry Intelligence Solutions

Products

COMPANY